Risk factors for bleeding in hepatocellular adenoma

被引:74
|
作者
Bieze, M. [1 ]
Phoa, S. S. K. S. [2 ]
Verheij, J. [3 ]
van Lienden, K. P. [4 ]
van Gulik, T. M. [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Dept Intervent Radiol, NL-1105 AZ Amsterdam, Netherlands
关键词
MCGILL PAIN QUESTIONNAIRE; FOCAL NODULAR HYPERPLASIA; BENIGN HEPATIC-TUMORS; MALIGNANT-TRANSFORMATION; LIVER;
D O I
10.1002/bjs.9493
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Hepatocellular adenoma (HCA) is a benign hepatic lesion that may be complicated by bleeding, although the risk of bleeding is ill-defined. The aim of this study was to assess risk factors for bleeding in patients diagnosed with HCA. Methods: Patients with HCA were included prospectively from January 2008 to July 2012. Patient characteristics were noted. Patients underwent dynamic magnetic resonance imaging (MRI) and/or computed tomography (CT) at presentation and during follow-up. Lesion characteristics on (follow-up) imaging were noted, and bleeding was graded as intratumoral (grade I), intrahepatic (grade II) or extrahepatic (grade III). The standard of reference for diagnosis was histopathology, or dynamic MRI and/or CT findings. Possible risk factors were included if mentioned in literature (lesion size, body mass index), or based on clinical experience (lesion location, visible vessels on imaging). Results: A total of 45 patients (median age 39 (range 22-60) years; 44 women) with 195 lesions (median size 24 (10-250) mm) were evaluated. Bleeding occurred in 29 patients (64 per cent) and in 42 lesions (21.5 per cent) with a median size of 62 (10-160) mm. Size was a risk factor for bleeding (P<0.001), with an increased number of bleeding events in lesions of 35mm or more. Exophytic lesions (protruding from liver) had more bleeding (16 of 24, 67 per cent) than intrahepatic (9 of 82, 11 per cent) or subcapsular (17 of 89, 19 per cent) lesions (P < 0.001). Lesions in segments II and III had more bleeds than those in the right liver (11 of 32 versus 31 of 163; P = 0.049), as did lesions in which peripheral or central arteries were visualized on imaging (10 of 13 versus 32 of 182 lesions with no visible vascularization; P < 0.001). Conclusion: Risk factors for bleeding of HCA include diameter of 35mm or more, visualization of lesional arteries, location in the left lateral liver, and exophytic growth.
引用
收藏
页码:847 / 855
页数:9
相关论文
共 50 条
  • [31] Hepatocellular adenoma as a risk factor for hepatocellular carcinoma in a non-cirrhotic liver: a plea against
    Witjes, Caroline D. M.
    ten Kate, Fiebo J. W.
    van Aalten, Susanna M.
    Dwarkasing, Roy S.
    Willemssen, Francois E. J. A.
    Verhoef, Cornelis
    de Man, Robert A.
    IJzermans, Jan N. M.
    GUT, 2012, 61 (11) : 1645 - 1646
  • [32] HEPATOCELLULAR ADENOMA OF THE PLACENTA
    CHEN, KTK
    MA, CK
    KASSEL, SH
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1986, 10 (06) : 436 - 440
  • [33] Hepatocellular Adenoma Risk Factors of Hemorrhage: Size Is Not the Only Concern! Single-center Retrospective Experience of 261 Patients
    Julien, Celine
    Le-Bail, Brigitte
    Touhami, Kevin Ouazzani
    Frulio, Nora
    Blanc, Jean-Frederic
    Adam, Jean-Philippe
    Laurent, Christophe
    Balabaud, Charles
    Bioulac-Sage, Paulette
    Chiche, Laurence
    ANNALS OF SURGERY, 2021, 274 (05) : 843 - 850
  • [34] Hepatocellular adenoma: An update
    Vijay, Adarsh
    Elaffandi, Ahmed
    Khalaf, Hatem
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (25) : 2603 - 2609
  • [35] STRATEGIES FOR HEPATOCELLULAR ADENOMA
    WEIMANN, A
    KLEMPNAUER, J
    LANGE, H
    RINGE, B
    PICHLMAYR, R
    BRITISH JOURNAL OF SURGERY, 1995, 82 : 101 - 101
  • [36] HEPATOCELLULAR ADENOMA OF THE LIVER
    KARYAKIN, AM
    USOLTSEVA, GE
    KHIRURGIYA, 1983, (07): : 114 - &
  • [37] A HEPATOCELLULAR ADENOMA IN A RATTLESNAKE
    HRUBAN, Z
    MASCHGAN, ER
    JOURNAL OF COMPARATIVE PATHOLOGY, 1982, 92 (03) : 429 - 435
  • [38] Hepatocellular adenoma: An update
    Adarsh Vijay
    Ahmed Elaffandi
    Hatem Khalaf
    World Journal of Hepatology, 2015, (25) : 2603 - 2609
  • [39] RISK OF BLEEDING AMONG INDIVIDUALS RECEIVING ORAL ANTICOAGULANTS WITH KNOWN BLEEDING RISK FACTORS
    Gomez-Lumbreras, A.
    Tan, M. S.
    Malone, D. C.
    VALUE IN HEALTH, 2022, 25 (07) : S316 - S316
  • [40] Risk factors of early re-bleeding and mortality in patients with ruptured gastric varices and concomitant hepatocellular carcinoma
    Chen-Jung Chang
    Ming-Chih Hou
    Wei-Chih Liao
    Fa-Yauh Lee
    Han-Chieh Lin
    Shou-Dong Lee
    Journal of Gastroenterology, 2012, 47 : 531 - 539